BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34431598)

  • 41. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
    Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
    BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toosendanin-induced apoptosis in colorectal cancer cells is associated with the κ-opioid receptor/β-catenin signaling axis.
    Wang H; Wen C; Chen S; Wang F; He L; Li W; Zhou Q; Yu WK; Huang L; Chen J; Liu R; Li W; Yang X; Liu H
    Biochem Pharmacol; 2020 Jul; 177():114014. PubMed ID: 32387457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.
    Li Q; Dashwood RH
    J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.
    Tao Q; Wu C; Xu R; Niu L; Qin J; Liu N; Zhang P; Wang C
    Cell Tissue Res; 2017 Dec; 370(3):379-390. PubMed ID: 28815294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
    Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting the Wnt signaling pathway in colorectal cancer.
    Sawa M; Masuda M; Yamada T
    Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
    Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
    J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
    Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
    Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
    Dieudonné FX; Marion A; Marie PJ; Modrowski D
    J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasticity of WNT signaling activity in colorectal cancer].
    Horst D
    Pathologe; 2012 Nov; 33 Suppl 2():194-7. PubMed ID: 22968731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
    Ren Y; Tao J; Jiang Z; Guo D; Tang J
    Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
    Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. γ-Catenin acts as a tumor suppressor through context-dependent mechanisms in colorectal cancer.
    Nagel JM; Lahm H; Ofner A; Göke B; Kolligs FT
    Int J Colorectal Dis; 2017 Sep; 32(9):1243-1251. PubMed ID: 28681073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway.
    Tong X; Zhuang Z; Wang X; Yang X; Bai L; Su L; Wei P; Su X
    Biomed Pharmacother; 2021 May; 137():111209. PubMed ID: 33581651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Henryin, an ent-kaurane diterpenoid, inhibits Wnt signaling through interference with β-catenin/TCF4 interaction in colorectal cancer cells.
    Li X; Pu J; Jiang S; Su J; Kong L; Mao B; Sun H; Li Y
    PLoS One; 2013; 8(7):e68525. PubMed ID: 23844215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
    Scholer-Dahirel A; Schlabach MR; Loo A; Bagdasarian L; Meyer R; Guo R; Woolfenden S; Yu KK; Markovits J; Killary K; Sonkin D; Yao YM; Warmuth M; Sellers WR; Schlegel R; Stegmeier F; Mosher RE; McLaughlin ME
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17135-40. PubMed ID: 21949247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
    Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
    Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
    Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.